Oral function should be measured routinely to determine individual bulbar involvement stages in spinal muscular atrophy (SMA). “Our results underscore the heterogeneity of oral function effort across ...

"Decreasing AMMO [active maximal mouth opening] over time is seen most often in patients with SMA type 2 with an estimated reduction of almost 1 mm per year...At this point, we propose that ...

Noninvasive ventilation (NIV) is a well-established treatment for breathing difficulties caused by amyotrophic lateral sclerosis (ALS), even though its use has not been investigated in a randomized, ...

Patients with SMA often suffer from impaired bulbar function, which negatively affects quality of life and can be difficult to treat effectively. A German study prospectively followed children with ...

(RTTNews) - Novartis (NVS) announced new data that reinforce the transformational benefit of Zolgensma (onasemnogene abeparvovec), an essential one-time treatment for spinal muscular atrophy or SMA.

Rozanolixizumab improved muscle weakness and fatigue in myasthenia gravis patients, as shown in the MycarinG study using MG Symptoms PRO scales. Strong correlations were found between MG Symptoms PRO ...